Assessment of Mammalian Target of Rapamycin Pathway Activation in Basal Cell Carcinoma as a New Therapeutic Approach.

Am J Dermatopathol · 2024 · PMC11328919 · PMID 38648034

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The GS BCC group (n = 25) demonstrated elevated cytoplasmic phospho-AKT staining intensities but did not reach statistical significance after Bonferroni correction due to small sample size.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.